超声增强的输送的物料进入并通过皮肤 翻译.docx

上传人:b****2 文档编号:3201394 上传时间:2023-05-05 格式:DOCX 页数:28 大小:58.39KB
下载 相关 举报
超声增强的输送的物料进入并通过皮肤 翻译.docx_第1页
第1页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第2页
第2页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第3页
第3页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第4页
第4页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第5页
第5页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第6页
第6页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第7页
第7页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第8页
第8页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第9页
第9页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第10页
第10页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第11页
第11页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第12页
第12页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第13页
第13页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第14页
第14页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第15页
第15页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第16页
第16页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第17页
第17页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第18页
第18页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第19页
第19页 / 共28页
超声增强的输送的物料进入并通过皮肤 翻译.docx_第20页
第20页 / 共28页
亲,该文档总共28页,到这儿已超出免费预览范围,如果喜欢就下载吧!
下载资源
资源描述

超声增强的输送的物料进入并通过皮肤 翻译.docx

《超声增强的输送的物料进入并通过皮肤 翻译.docx》由会员分享,可在线阅读,更多相关《超声增强的输送的物料进入并通过皮肤 翻译.docx(28页珍藏版)》请在冰点文库上搜索。

超声增强的输送的物料进入并通过皮肤 翻译.docx

超声增强的输送的物料进入并通过皮肤翻译

Ultrasound-enhanceddeliveryofmaterialsintoandthroughtheskin

Amethodforenhancingthepermeabilityoftheskinorotherbiologicalmembranetoamaterialsuchasadrugisdisclosed.Inthemethod,thedrugisdeliveredinconjunctionwithultrasoundhavingafrequencyofaboveabout10MHz.Themethodmayalsobeusedinconjunctionwithchemicalpermeationenhancersand/orwithiontophoresis.

图片(11)

 

 

 

 

 

 

 

 

 

 

 

权利要求(21)

Weclaim:

1.Amethodforenhancingtherateofpermeationofadrugmediumintoaselectedintactareaofanindividual'sbodysurface,whichmethodcomprises:

(a)applyingultrasoundhavingafrequencyofabove10MHztosaidselectedarea,atanintensityandforaperiodoftimeeffectivetoenhancethepermeabilityofsaidselectedarea;

(b)contactingtheselectedareawiththedrugmedium;and

(c)effectingpassageofsaiddrugmediumintoandthroughsaidselectedareabymeansofiontophoresis.

2.Themethodofclaim1,whereinsaidultrasoundfrequencyisintherangeofabout15MHzto50MHz.

3.Themethodofclaim2,whereinsaidultrasoundfrequencyisintherangeofabout15to25MHz.

4.Themethodofclaim1,whereinsaidperiodoftimeisintherangeofabout5to45minutes.

5.Themethodofclaim4,whereinsaidperiodoftimeisintherangeofabout5to30minutes.

6.Themethodofclaim1,whereinsaidperiodoftimeislessthanabout10minutes.

7.Themethodofclaim1,whereinsaidintensityofsaidultrasoundislessthanabout5.0W/cm.sup.2.

8.Themethodofclaim7,whereinsaidintensityofsaidultrasoundisintherangeofabout0.01to5.0W/cm.sup.2.

9.Themethodofclaim8,whereinsaidintensityofsaidultrasoundisintherangeofabout0.05to3.0W/cm.sup.2.

10.Themethodofclaim1,whereinsaidareaofthestratumcorneumisintherangeofabout1to100cm.sup.2.

11.Themethodofclaim10,whereinsaidareaofthestratumcorneumisintherangeofabout5to100cm.sup.2.

12.Themethodofclaim11,whereinsaidareaofthestratumcorneumisintherangeofabout10to50cm.sup.2.

13.Themethodofclaim1whereinsaiddrugmediumcomprisesadrugandacouplingagenteffectivetotransfersaidultrasoundtothebodyfromanultrasoundsource.

14.Themethodofclaim13whereinsaidcouplingagentisapolymeroragel.

15.Themethodofclaim13whereinsaidcouplingagentisselectedfromthegroupconsistingofglycerin,water,andpropyleneglycol.

16.Themethodofclaim1whereinsaiddrugmediumfurthercomprisesachemicalpermeationenhancer.

17.Themethodofclaim1,whereinsteps(a)and(b)arecarriedoutapproximatelysimultaneously.

18.Themethodofclaim1,whereinstep(b)iscarriedoutbeforestep(a).

19.Themethodofclaim1,whereinstep(a)iscarriedoutbeforestep(b).

20.Themethodofclaim1,whereintheultrasoundisappliedcontinuously.

21.Themethodofclaim1,whereintheultrasoundispulsed.

说明

ThisapplicationisadivisionofapplicationSer.No.07/844,732filedMar.2,1992,nowU.S.Pat.No.5,231,975whichisadivisionalofapplicationSer.No.07/484,560,nowU.S.Pat.No.5,115,805,filedFeb.23,1990.

TECHNICALFIELD

Thisinventionrelatesgenerallytothefieldofdrugdelivery.Moreparticularly,theinventionrelatestoamethodofenhancingtherateofpermeationoftopically,transmucosallyortransdermallyappliedmaterialsusinghighfrequencyultrasound.

BACKGROUND

Thedeliveryofdrugsthroughtheskin("transdermaldrugdelivery"or"TDD")providesmanyadvantages;primarily,suchameansofdeliveryisacomfortable,convenientandnon-invasivewayofadministeringdrugs.Thevariableratesofabsorptionandmetabolismencounteredinoraltreatmentareavoided,andotherinherentinconveniences--e.g.,gastrointestinalirritationandthelike--areeliminatedaswell.Transdermaldrugdeliveryalsomakespossibleahighdegreeofcontroloverbloodconcentrationsofanyparticulardrug.

Skinisastructurallycomplex,relativelyimpermeablemembrane.Moleculesmovingfromtheenvironmentintoandthroughintactskinmustfirstpenetratethestratumcorneumandanymaterialonitssurface.Theymustthenpenetratetheviableepidermis,thepapillarydermis,andthecapillarywallsintothebloodstreamorlymphchannels.Tobesoabsorbed,moleculesmustovercomeadifferentresistancetopenetrationineachtypeoftissue.Transportacrosstheskinmembraneisthusacomplexphenomenon.However,itisthestratumcorneum,alayerapproximately5-15micrometersthickovermostofthebody,whichpresentstheprimarybarriertoabsorptionoftopicalcompositionsortransdermallyadministereddrugs.Itisbelievedtobethehighdegreeofkeratinizationwithinitscellsaswellastheirdensepackingandcementationbyordered,semicrystallinelipidswhichcreateinmanycasesasubstantiallyimpermeablebarriertodrugpenetration.Applicabilityoftransdermaldrugdeliveryisthuspresentlylimited,becausetheskinissuchanexcellentbarriertotheingressoftopicallyappliedmaterials.Forexample,manyofthenewpeptidesandproteinsnowproducedasaresultofthebiotechnologyrevolutioncannotbedeliveredacrosstheskininsufficientquantitiesduetotheirnaturallylowratesofskinpermeability.

Variousmethodshavebeenusedtoincreaseskinpermeability,andinparticulartoincreasethepermeabilityofthestratumcorneum(i.e.,soastoachieveenhancedpenetration,throughtheskin,ofthedrugtobeadministeredtransdermally).Theprimaryfocushasbeenontheuseofchemicalenhancers,i.e.,whereindrugiscoadministeredwithapenetrationenhancingagent(or"permeationenhancer").Whilesuchcompoundsareeffectiveinincreasingtherateatwhichdrugisdeliveredthroughtheskin,therearedrawbackswithmanypermeationenhancerswhichlimittheiruse.Forexample,manypermeationenhancersareassociatedwithdeleteriouseffectsontheskin(e.g.,irritation).Inaddition,controlofdrugdeliverywithchemicalenhancementcanbequitedifficult.

Iontophoresishasalsobeenusedtoincreasethepermeabilityofskintodrugs,andinvolves

(1)theapplicationofanexternalelectricfield,and

(2)topicaldeliveryofanionizedformofdrug(orofaneutraldrugcarriedwiththewaterfluxassociatedwithiontransport,i.e.,via"electroosmosis").Whilepermeationenhancementviaiontophoresishas,aswithchemicalenhancers,beeneffective,thereareproblemswithcontrolofdrugdeliveryandthedegreeofirreversibleskindamageinducedbythetransmembranepassageofcurrent.

Thepresentlydisclosedandclaimedmethodinvolvestheuseofultrasoundtodecreasethebarrierfunctionofthestratumcorneumandthusincreasetherateatwhichadrugmaybedeliveredthroughtheskin."Ultrasound"isdefinedasmechanicalpressurewaveswithfrequenciesabove20,000Hz(see,e.g.,H.Lutzetal.,ManualofUltrasound:

1.BasicPhysicalandTechnicalPrinciples(Berlin:

Springer-Verlag,1984)).

AsdiscussedbyP.Tyleetal.inPharmaceuticalResearch6(5):

355-361(1989),drugpenetrationachievedvia"sonophoresis"(themovementofdrugsthroughskinundertheinfluenceofanultrasonicperturbation;seeD.M.SkauenandG.M.Zentner,Int.J.Pharmaceutics20:

235-245(1984)),isbelievedtoresultfromthermal,mechanicalandchemicalalterationofbiologicaltissuesbytheappliedultrasonicwaves.Unlikeiontophoresis,theriskofskindamageappearstobelow.

Applicationsofultrasoundtodrugdeliveryhavebeendiscussedintheliterature.See,forexample:

P.Tyleetal.,supra(whichprovidesanoverviewofsonophoresis);S.Miyazakietal.,J.Pharm.Pharmacol.40:

716-717(1988)(controlledreleaseofinsulinfromapolymerimplantusingultrasound);J.Kostetal.,Proceed.Intern.Symp.Control.Rel.Bioact.Mater.16(141):

294-295(1989)(overviewoftheeffectofultrasoundonthepermeabilityofhumanskinandsyntheticmembranes);H.Bensonetal.,PhysicalTherapy69

(2):

113-118(1989)(effectofultrasoundonthepercutaneousabsorptionofbenzydamine);E.Novak,Arch.Phys.Medicine&Rehab.45:

231-232(1964)(enhancedpenetrationoflidocainethroughintactskinusingultrasound);J.E.Griffinetal.,Amer.J.Phys.Medicine44

(1):

20-25(1965)(ultrasonicpenetrationofcortisolintopigtissue);J.E.Griffinetal.,J.Amer.Phys.TherapyAssoc.46:

18-26(1966)(overviewoftheuseofultrasonicenergyindrugtherapy);J.E.Griffinetal.,Phys.Therapy47(7):

594-601(1967)(ultrasonicpenetrationofhydrocortisone);J.E.Griffinetal.,Phys.Therapy48(12):

1336-1344(1968)(ultrasonicpenetrationofcortisolintopigtissue);J.E.Griffinetal.,Amer.J.Phys.Medicine51

(2):

62-72(1972)(same);J.C.McElnay,Int.J.Pharmaceutics40:

105-110(1987)(theeffectofultrasoundonthepercutaneousabsorptionoffluocinoloneacetonide);andC.Escoffieretal.,Bioeng.Skin2:

87-94(1986)(invitrostudyofthevelocityofultrasoundinskin).

Inadditiontotheaforementionedart,U.S.Pat.Nos.4,767,402and4,780,212toKostetal.relatespecificallytotheuseofspecificfrequenciesofultrasoundtoenhancetherateofpermeationofadrugthroughhumanskinorthroughasyntheticmembrane.

Whiletheapplicationofultrasoundinconjunctionwithdrugdeliveryisthusknown,resultshaveforthemostpartbeendisappointing,i.e.,enhancementofskinpermeabilityhasbeenrelativelylow.

SUMMARYOFTHEINVENTION

Thepresentinventionprovidesanovelmethodforenhancingtherateofpermeationofagivenmaterialthroughaselectedintactareaofanindividual'sbodysurface.Themethodcomprisescontactingtheselectedintactareawiththematerialandapplyingultrasoundtothecontactedarea.Theu

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 解决方案 > 学习计划

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2